CERTARA INC. - COMMON
10.99
07-十一月-24 15:59:58
15 分钟延时
股票
+0.08
+0.73%
今日范围
10.08 - 11.02
ISIN
N/A
来源
NASDAQ
-
Certara Reports Third Quarter 2022 Financial Results
07 11月 2022 16:15:01 条件 Nasdaq GlobeNewswire
-
07 11月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
02 11月 2022 17:00:00 条件 Nasdaq GlobeNewswire
-
19 10月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
13 10月 2022 07:45:00 条件 Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
31 8月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Certara Announces Secondary Offering
11 8月 2022 16:38:42 条件 Nasdaq GlobeNewswire
-
Certara Reports Second Quarter 2022 Financial Results
09 8月 2022 16:15:01 条件 Nasdaq GlobeNewswire
-
Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module
05 8月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies
28 7月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Certara Appoints Rosemary Crane as New Independent Board Member
25 7月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Certara Appoints Eran Broshy as New Independent Board Member
13 7月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
12 7月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
28 6月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics
21 6月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Certara Reports First Quarter 2022 Financial Results
05 5月 2022 16:15:00 条件 Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
03 5月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Certara to Report First Quarter 2022 Financial Results on May 5th, 2022
20 4月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Certara Reports Fourth Quarter and Full Year 2021 Financial Results
01 3月 2022 16:15:00 条件 Nasdaq GlobeNewswire
-
U.S. FDA Licenses Certara’s Immunogenicity Simulator
23 2月 2022 16:30:00 条件 Nasdaq GlobeNewswire